BioAesthetics
6 known investors
BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue. It targets breast cancer survivors who have undergone mastectomies and lost their nipples, operating in the biomaterials and medical device field.
Founders & leadership
JB
Juliana BlumCEO & Director
BH
Billy HeiminCOO
Investors · 6
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $874.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $258.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $308.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2021 | $251.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BioAesthetics do?
- BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue. It targets breast cancer survivors who have undergone mastectomies and lost their nipples, operating in the biomaterials and medical device field.
- Who founded BioAesthetics?
- BioAesthetics was founded by Juliana Blum.
- Who are BioAesthetics's investors?
- BioAesthetics's investors include FemHealth Ventures, Hemi Ventures, Llc, Joyance Partners, New Orleans Startup Fund, The Launch Place, IndieBio.